QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)
QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)
QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)
QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)
Free Trial
NASDAQ:BIOT

Biotech Acquisition (BIOT) Stock Price, News & Analysis

→ REVEALED: Elon Musk’s Secret A.I. Facility? (From InvestorPlace) (Ad)
Free BIOT Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$10.14
▼
$10.19
50-Day Range
$10.08
▼
$10.32
52-Week Range
$8.30
▼
$10.41
Volume
44,400 shs
Average Volume
244,605 shs
Market Capitalization
$291.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
BIOT stock logo

About Biotech Acquisition Stock (NASDAQ:BIOT)

Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

BIOT Stock News Headlines

April 15, 2024 | finance.yahoo.com
Global Directory Unveils Top 1,000 Pharmaceutical and Biotechnology Companies for 2024
April 12, 2024 | bizjournals.com
Eliem pursues acquisition of New Jersey biotech after halting programs
April 16, 2024 | InvestorPlace (Ad)
REVEALED: Elon Musk’s Secret A.I. Facility?
I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.
April 11, 2024 | finance.yahoo.com
Vertex Pharmaceuticals Incorporated: Vertex: $4.9 Billion Acquisition of Alpine Immune Sciences Expands Kidney-Disease Portfolio
April 10, 2024 | marketwatch.com
Vera Therapeutics Shares Rise 9.9% After Alpine Acquisition
April 10, 2024 | bizjournals.com
Vertex to acquire Seattle biotech for $4.9B
April 10, 2024 | msn.com
Vertex buying Seattle biotech for $4.9 billion, its biggest acquisition ever
April 8, 2024 | bizjournals.com
Biotech layoffs tracker: 14 biotechs cut over 300 jobs in Q1 2024
April 16, 2024 | InvestorPlace (Ad)
REVEALED: Elon Musk’s Secret A.I. Facility?
I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.
April 6, 2024 | finance.yahoo.com
2 Biotech Stocks to Buy Hand Over Fist in April
April 5, 2024 | finance.yahoo.com
Johnson & Johnson: J&J: Shockwave Acquisition Adds Fast-Growing Medical Devices
April 4, 2024 | msn.com
Bristol Myers Squibb to lay off hundreds of workers following its $4.8B merger with this San Diego biotech
April 4, 2024 | markets.businessinsider.com
Mitsui & Co., ROHTO Pharmaceutical To Acquire Shares In Eu Yan Sang International
April 4, 2024 | marketwatch.com
Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update
April 3, 2024 | msn.com
Genmab Strengthens Oncology Portfolio With $1.8 Billion Acquisition of ProfoundBio
April 2, 2024 | bizjournals.com
Merz offers $185 million for assets of bankrupt biotech
April 2, 2024 | finance.yahoo.com
Apotex to Acquire Searchlight Pharma, a Canadian Specialty Branded Pharmaceutical Leader
April 2, 2024 | bizjournals.com
March M&A roundup: Biotech, buyers, and digital health
April 1, 2024 | finance.yahoo.com
Vallen Distribution Completes Acquisition of Wesco Integrated Supply
March 31, 2024 | seekingalpha.com
Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer Candidate
March 27, 2024 | marketwatch.com
Biotech Group Acquisition Withdraws IPO
March 26, 2024 | wsj.com
M&A Gathers Steam for Biotech Startups
March 21, 2024 | fool.com.au
Why this exciting ASX biotech stock could be a future star
March 21, 2024 | bizjournals.com
Zoning barriers and limited space: How biotech can expand on L.A.'s Westside
March 19, 2024 | bizjournals.com
PureTech made millions on Karuna acquisition. Here’s what it plans to return to shareholders.
March 19, 2024 | bizjournals.com
AstraZeneca bets $2B on Canada-Boston biotech
March 19, 2024 | markets.businessinsider.com
UK Stocks: AstraZeneca (AZN) Expands Cancer Portfolio with Fusion Pharma Acquisition
See More Headlines
Receive BIOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/15/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOT
CUSIP
N/A
CIK
1825413
Web
bioacq.com
Phone
212-227-1905
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-6,860,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-42.22%
Return on Assets
3.48%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.03
Quick Ratio
0.03

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.95) per share
Price / Book
-10.68

Miscellaneous

Outstanding Shares
28,750,000
Free Float
23,288,000
Market Cap
$291.81 million
Optionable
Not Optionable
Beta
-0.12
12 Stocks Corporate Insiders are Abandoning Cover
12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Dr. Michael Shleifer Ph.D. (Age 48)
    Chairman & CEO
  • Mr. Thomas Fratacci (Age 44)
    CFO & Treasurer
  • Mr. Ivan Jarry (Age 44)
    Chief Operating Officer
  • Mr. Albert F. Hummel M.B.A. (Age 76)
    Chief Investment Officer & Director

Key Competitors

View All Competitors

This page (NASDAQ:BIOT) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
He Is Giving Away Bitcoin
Crypto Swap Profits
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Options trading has suddenly become more reliable.
Eagle Publishing
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press